SCHEMBL18320673

SCHEMBL18320673

Cc1nn(Cc2ccccc2)c(C)c1NC(=O)c1cc(-c2ccccc2)nc2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 5/20 0.65
PTGER4 P35408 4/20 0.63
SLC2A3 P11169 4/20 0.61
SLC2A4 P14672 4/20 0.61
TACR3 P29371 1/20 0.57
CYP3A4 P08684 2/20 0.57
ALDH1A1 P00352 2/20 0.56
SLC2A2 P11168 1/20 0.55
HTT P42858 2/20 0.55
LMNA P02545 3/20 0.55
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
MAPT P10636 1/20 0.53
GFER P55789 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18320705 0.93 SLC2A1 (0.76) SLC2A1PTGER4SLC2A3SLC2A4CYP3A4
SCHEMBL18320637 0.89 PTGER4 (0.66) SLC2A1PTGER4SLC2A3SLC2A4CYP3A4
Hydrochloric Acid SCHEMBL18320751 0.88 PTGER4 (0.64) SLC2A1PTGER4SLC2A3SLC2A4CYP3A4
SCHEMBL18320547 0.87 SLC2A1 (0.74) SLC2A1PTGER4SLC2A3SLC2A4CYP3A4
SCHEMBL18320858 0.86 SLC2A1 (0.73) SLC2A1PTGER4SLC2A3SLC2A4SLC2A2
SCHEMBL18320734 0.86 SLC2A1 (0.73) SLC2A1PTGER4SLC2A3SLC2A4ALDH1A1
SCHEMBL18320724 0.86 SLC2A1 (0.71) SLC2A1SLC2A3SLC2A4CYP3A4SLC2A2
SCHEMBL18320989 0.86 SLC2A1 (0.69) SLC2A1PTGER4SLC2A3SLC2A4SLC2A2
SCHEMBL18321238 0.86 SLC2A1 (0.73) SLC2A1PTGER4SLC2A3SLC2A4SLC2A2
SCHEMBL18320824 0.86 SLC2A1 (0.66) SLC2A1PTGER4SLC2A3SLC2A4SLC2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016202898-A1 GLUCOSE TRANSPORT INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-12-22 WO claimed
WO-2016202898-A1 GLUCOSE TRANSPORT INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-12-22 WO disclosed